LRT Capital Management LLC lessened its holdings in Chemed Corporation (NYSE:CHE – Free Report) by 14.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,574 shares of the company’s stock after selling 1,247 shares during the quarter. Chemed accounts for approximately 2.8% of LRT Capital Management LLC’s holdings, making the stock its 4th biggest holding. LRT Capital Management LLC owned approximately 0.05% of Chemed worth $3,241,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Northwestern Mutual Wealth Management Co. increased its holdings in Chemed by 2,444,879.3% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company’s stock valued at $2,374,667,000 after buying an additional 5,549,876 shares during the period. JPMorgan Chase & Co. increased its holdings in Chemed by 4.4% in the 4th quarter. JPMorgan Chase & Co. now owns 521,900 shares of the company’s stock valued at $223,301,000 after buying an additional 21,932 shares during the period. William Blair Investment Management LLC increased its holdings in Chemed by 13.6% in the 3rd quarter. William Blair Investment Management LLC now owns 385,124 shares of the company’s stock valued at $172,435,000 after buying an additional 46,038 shares during the period. TD Asset Management Inc increased its holdings in Chemed by 7.5% in the 4th quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock valued at $138,860,000 after buying an additional 22,715 shares during the period. Finally, Epoch Investment Partners Inc. increased its holdings in Chemed by 4.9% in the 4th quarter. Epoch Investment Partners Inc. now owns 322,408 shares of the company’s stock valued at $137,945,000 after buying an additional 15,133 shares during the period. Institutional investors own 95.85% of the company’s stock.
Chemed Stock Down 0.4%
CHE opened at $419.07 on Friday. The firm’s 50-day simple moving average is $415.27 and its 200-day simple moving average is $424.51. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85. Chemed Corporation has a twelve month low of $365.20 and a twelve month high of $562.77. The firm has a market cap of $5.56 billion, a price-to-earnings ratio of 22.84, a PEG ratio of 1.57 and a beta of 0.54.
Chemed Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th will be issued a $0.60 dividend. The ex-dividend date of this dividend is Thursday, May 28th. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. Chemed’s dividend payout ratio is presently 13.08%.
Insider Activity
In other news, Director Andrea R. Lindell sold 1,347 shares of the company’s stock in a transaction dated Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total value of $602,553.51. Following the sale, the director owned 4,578 shares of the company’s stock, valued at approximately $2,047,876.74. This represents a 22.73% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction dated Friday, May 1st. The stock was sold at an average price of $421.13, for a total transaction of $842,260.00. Following the sale, the chief executive officer directly owned 90,219 shares in the company, valued at approximately $37,993,927.47. This represents a 2.17% decrease in their position. The disclosure for this sale is available in the SEC filing. 3.33% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
CHE has been the topic of several analyst reports. Oppenheimer lowered their price target on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, February 27th. Wall Street Zen lowered shares of Chemed from a “buy” rating to a “hold” rating in a report on Monday, June 8th. Weiss Ratings raised shares of Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Finally, Royal Bank Of Canada boosted their price target on shares of Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a report on Monday, April 27th. Two equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $501.50.
View Our Latest Analysis on CHE
Chemed Company Profile
Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.
The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.
See Also
- Five stocks we like better than Chemed
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.
